Publishing activity of the University

 
After 2022
V1
V2
V3
O1
O2
O3
P1
D1
I1
I2
I3
        
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
 
Year
Cat
Year
Category
Publication
2024
V3
2024
V3
BUŠÁNYOVÁ, Beáta - VAJTER, Marie - KELIFOVÁ, Silvie - LIŠKOVÁ, Petra - MIKOVÁ, Hedviga - BRECIKOVÁ, Katarína - ŽIGMOND, Ján - ROGALEWICZ, Vladimír - TICHOPÁD, Aleš - VIŠŇANSKÝ, Martin - ŠARKANOVÁ, Ivana. Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective. In: Heliyon. 2024. ISSN 2405-8440, Vol. 10, no. 11 (2024), art. no. e32296, p. [1-8]
2024
V3
2024
V3
HAWLINA, Marko - KOVAČ, Lea - BRECIKOVÁ, Katarína - ŽIGMOND, Ján - ROGALEWICZ, Vladimír - TICHOPÁD, Aleš - VIŠŇANSKÝ, Martin - ŠARKANOVÁ, Ivana. Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective. In: Orphanet journal of rare diseases volume. 2024. ISSN 1750-1172, Vol. 19, no. 1 (2024), art. no. 318, p. [1-6]
2024
V3
2024
V3
BUCEK PŠENKOVÁ, Mária - HLAVINKOVÁ, Lucia - VIŠŇANSKÝ, Martin - GREGA, Dominik - ONDRUŠOVÁ, Martina. The checklist for standard methodological requirements and reporting of economic evaluation of medicines in Slovakia. In: Value in Health Regional Issues. 2024. ISSN 2212-1099, Vol. 39, no. (2024), p. 14-19.
(2022: 2.000 - IF, 23 - H-index, 0.456 - SJR, Q2 - SJR Best Q)
2022
V3
2022
V3
GREGA, Dominik - KOLÁŘ, Jozef - VIŠŇANSKÝ, Martin. Average CET limit: Is it possible to introduce a single CET for the whole EEA?. In: ISPOR Europe. Value In Health. 2022. 2022. ISSN 1098-3015, Vol. 25, no. 12, suppl. (2022), p. 557.
2020
BCI
2020
BCI
KORIMOVÁ, Jana - VIŠŇANSKÝ, Martin. Manažment pre študentov farmácie [Management for Pharmacy Students]. Rec. Jaroslav Legáth, Tomáš Wolaschka. 1. vyd. Košice : UVLF 2020. ISBN 978-80-8077-692-3, 107 s. [6AH] [6,00 AH]
2020
BCI
2020
BCI
KORIM, Peter - FEDOROVÁ, Monika - VIŠŇANSKÝ, Martin. Základy práva pre študentov farmácie [Basics of Law for Pharmacy Students]. Rec. Jaroslav Legáth, Tomáš Wolaschka. 1. vyd. Košice : UVLF 2020. ISBN 978-80-8077-693-0, 150 s. [14,4AH] [11,4 AH]
2019
AFD
2019
AFD
VIŠŇANSKÝ, Martin. Financovanie inovatívnych medicínskych technológií [Financing the innovative health technologies]. In: Škola - Veda - Prax, 17.-18. september 2019, Košice : Zborník referátov a abstraktov: vedecká konferencia pri príležitosti 70. výročia založenia UVLF v Košiciach. 1. vyd. Košice : UVLF, 2019. 2019. ISBN 978-80-8077-628-2, CD-ROM, s. 158-160.
2018
ADF
2018
ADF
VIŠŇANSKÝ, Martin. Hodnotenie hodnotení - lieky (2016-2017). In: Farmakoekonomika a lieková politika. 2018. ISSN 1336-7021, Roč. 14, č. 1(2018), s. 57-58.
2018
AFG
2018
AFG
VIŠŇANSKÝ, Martin - BUTALOVÁ, Anna. Impact of the international reference pricing on access to standard therapy drugs for copd [Dopad medzinárodného referencovania cien na dostupnosť štandardnej terapie pre liečbu CHOCHP]. In: ISPOR Europe 2018-New perspectives for improving 21st century health systems. Value In Health. 2018. 2018. ISSN 1098-3015, Vol. 21, suppl. 3 (2018), p. 415-416.
2018
AFG
2018
AFG
VIŠŇANSKÝ, Martin. Is transparency in slovak hta efficient enought? Comparing pharmacoeconomics methodologies used in pricing & reimbursement applications for innovative therapies towards requirements defined by the law [Je hodnotenie zdravotníckych technológii na Slovensku dostatočne transparentne? Porovnanie farmakoekonomických metód, používaných pri podaní žiadostí o cenu a úhradu pre inovatívne lieky v porovnaní s požiadavkami zákona]. In: ISPOR Europe 2018-New perspectives for improving 21st century health systems. Value In Health. 2018. 2018. ISSN 1098-3015, Vol. 21, suppl. 3 (2018), p. 318.
Last database update: 08. 10. 2024 08:37
Number of records in database: 27
Page 1 / 3